About Slingshot Biosciences
Slingshot Biosciences is a private company based in Emeryville, California. It has reported $49,107,244 raised in two offerings on Form D since June 2021. Its chief executive is Jeffrey Kim.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 24, 2023 | Feb 6, 2023amended Apr 26, 2024 | $26,227,275fully sold | 10 | $2.6M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| May 28, 2021 | Jun 14, 2021amended Jul 23, 2021 | $22,879,969fully sold | 17 | $1.3M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $49,107,244 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Slingshot Biosciences's Form D filed Apr 26, 2024.
NB
Nicolas Barthelemy
Director
PW
CR
Corey Ritter
Director
AL
Andrew Lee
Director
RS
Ronald Silberman
Director
JK
Jeffrey Kim
Chief Executive Officer and director
Earlier filings also listed Adam Wieschhaus (director, last listed Jul 2021).